ALDH1A1 and fibrosarcoma: More so, these determinations were based on the flow cytometric-based Aldefluor assay, not IHC. Additionally, Honoki et al. found that human OS and fibrosarcoma cells with elevated ALDH1A1 were more resistant to cisplatin and doxorubicin in vitro [24].